The TElemonitoring in the Management of Heart Failure (TEMA-HF) 1 Long-term Follow-up Study
NCT ID: NCT03171038
Last Updated: 2017-06-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
160 participants
INTERVENTIONAL
2008-04-01
2015-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Telemedical Interventional Monitoring in Heart Failure
NCT00543881
Tele-HF: Yale Heart Failure Telemonitoring Study
NCT00303212
Telemedical Interventional Management in Heart Failure II
NCT01878630
Management of Telemedicine Monitoring of Patients With Chronic Heart Failure
NCT05885425
REsponsible roLl-out of E-heAlth Through Systematic Evaluation - Heart Failure Study
NCT05654961
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The usual care (UC) patients received ususal care during the first six months, followed by standard heart failure care until the long-term follow-up evaluation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Telemonitoring group
6 months of telemonitoring (t0-t1), followed by usual care up until common long-term stopping date (t1-t2).
Telemonitoring
Usual care group
Usual care from t0 up until the common stopping date (t2).
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Telemonitoring
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Treated for heart failure according to current guidelines
* ≥ 18 years of age
* Able to provide informed consent
Exclusion Criteria
* Presence of severe aortic stenosis
* Previous residency in a nursing home
* Inclusion in a cardiac rehabilitation program on discharge
* Chronic kidney disease stage ≥ 4
* Planned dialysis in the next six months
* Life expectancy \< 1 year due to non-heart failure related reasons
* Severe chronic obstructive pulmonary disease, GOLD ≥ III
* Cognitive and/or mental problems interfering with the performance of daily measurements and data transmission
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hasselt University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
prof. dr. Paul Dendale
Prof. dr.
References
Explore related publications, articles, or registry entries linked to this study.
Frederix I, Vanderlinden L, Verboven AS, Welten M, Wouters D, De Keulenaer G, Ector B, Elegeert I, Troisfontaines P, Weytjens C, Mullens W, Dendale P. Long-term impact of a six-month telemedical care programme on mortality, heart failure readmissions and healthcare costs in patients with chronic heart failure. J Telemed Telecare. 2019 Jun;25(5):286-293. doi: 10.1177/1357633X18774632. Epub 2018 May 10.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Jessa Hospital
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.